Table 4.

Age-specific rates, crude rates, European age-standardized rates, and incidence sex ratio of all lymphomas and lymphoma subgroups by sex and age group.

		Age-specific rate
Sex	N	<1	1–4	5–9	10–14	CR	(CR 95%CI)	ASRE	(ASRE 95%CI)	ISR
II. Lymphomas and reticuloendothelial neoplasms
Both	1,488	10.9	16.1	20.5	24.1	20.1	(19.1; 21.1)	20.0	(19.0; 21.1)	2.0
Boys	1,010	11.7	22.2	28.4	30.4	26.5	(24.9; 28.2)	26.5	(24.9; 28.1)
Girls	478	10.1	9.6	12.2	17.4	13.3	(12.1; 14.5)	13.2	(12.0; 14.4)
IIa. Hodgkin lymphomas
Both	449	0.0	1.0	5.2	11.5	6.1	(5.5; 6.6)	6.0	(5.4; 6.5)	1.5
Boys	276	0.0	1.8	7.2	12.4	7.3	(6.4; 8.1)	7.2	(6.3; 8.0)
Girls	173	0.0	0.2	3.1	10.4	4.8	(4.1; 5.5)	4.7	(4.0; 5.4)
IIb. Non-Hodgkin lymphomas (except Burkitt’s lymphoma)
Both	443	1.6	4.9	6.8	6.8	6.0	(5.4; 6.5)	6.0	(5.4; 6.5)	2.3
Boys	312	1.7	6.5	9.5	9.3	8.2	(7.3; 9.1)	8.2	(7.3; 9.1)
Girls	131	1.4	3.2	3.9	4.1	3.6	(3.0; 4.3)	3.6	(3.0; 4.3)
IIc. Burkitt’s lymphoma
Both	393	0.2	6.6	6.3	4.4	5.3	(4.8; 5.8)	5.3	(4.8; 5.9)	3.6
Boys	312	0.4	10.8	9.3	6.7	8.2	(7.3; 9.1)	8.2	(7.3; 9.1)
Girls	81	0.0	2.1	3.1	2.0	2.3	(1.8; 2.7)	2.3	(1.8; 2.8)
IId. Miscellaneous lymphoreticular neoplasms
Both	172	8.9	3.4	1.7	1.0	2.3	(2.0; 2.7)	2.3	(2.0; 2.7)	1.1
Boys	92	9.5	3.1	1.7	1.4	2.4	(1.9; 2.9)	2.4	(1.9; 2.9)
Girls	80	8.3	3.8	1.7	0.6	2.2	(1.7; 2.7)	2.3	(1.8; 2.7)
IIe. Unspecified and other specified lymphomas
Both	31	0.2	0.2	0.6	0.4	0.4	(0.3; 0.6)	0.4	(0.3; 0.6)	1.3
Boys	18	0.0	0.1	0.7	0.6	0.5	(0.3; 0.7)	0.5	(0.3; 0.7)
Girls	13	0.5	0.3	0.5	0.2	0.4	(0.2; 0.6)	0.4	(0.2; 0.6)

CR, crude rate; ASR_E, age-standardized rate using the 2013 European population; CI, confidence interval; ISR, incidence sex ratio.